These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16946102)

  • 1. Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse.
    Hyde LA; McHugh NA; Chen J; Zhang Q; Manfra D; Nomeir AA; Josien H; Bara T; Clader JW; Zhang L; Parker EM; Higgins GA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1133-43. PubMed ID: 16946102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state.
    Panza F; Frisardi V; Imbimbo BP; Capurso C; Logroscino G; Sancarlo D; Seripa D; Vendemiale G; Pilotto A; Solfrizzi V
    CNS Neurosci Ther; 2010 Oct; 16(5):272-84. PubMed ID: 20560993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian Models in Alzheimer's Research: An Update.
    Sharma H; Chang KA; Hulme J; An SSA
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch-ing up knowledge on molecular mechanisms of skin fibrosis: focus on the multifaceted Notch signalling pathway.
    Condorelli AG; El Hachem M; Zambruno G; Nystrom A; Candi E; Castiglia D
    J Biomed Sci; 2021 May; 28(1):36. PubMed ID: 33966637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
    Ghanbari-Movahed M; Ghanbari-Movahed Z; Momtaz S; Kilpatrick KL; Farzaei MH; Bishayee A
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33673088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank.
    Vitek MP; Araujo JA; Fossel M; Greenberg BD; Howell GR; Rizzo SJS; Seyfried NT; Tenner AJ; Territo PR; Windisch M; Bain LJ; Ross A; Carrillo MC; Lamb BT; Edelmayer RM
    Alzheimers Dement (N Y); 2020; 6(1):e12114. PubMed ID: 33457489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Notch Signaling and Colorectal Cancer.
    Tyagi A; Sharma AK; Damodaran C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32630477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease.
    Wu WL; Domalski M; Burnett DA; Josien H; Bara T; Rajagopalan M; Xu R; Clader J; Greenlee WJ; Brunskill A; Hyde LA; Del Vecchio RA; Cohen-Williams ME; Song L; Lee J; Terracina G; Zhang Q; Nomeir A; Parker EM; Zhang L
    ACS Med Chem Lett; 2012 Nov; 3(11):892-6. PubMed ID: 24900404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a Potent Pyrazolopyridine Series of γ-Secretase Modulators.
    Qin J; Zhou W; Huang X; Dhondi P; Palani A; Aslanian R; Zhu Z; Greenlee W; Cohen-Williams M; Jones N; Hyde L; Zhang L
    ACS Med Chem Lett; 2011 Jun; 2(6):471-6. PubMed ID: 24900332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Discovery of Pyridone and Pyridazone Heterocycles as γ-Secretase Modulators.
    Huang X; Aslanian R; Zhou W; Zhu X; Qin J; Greenlee W; Zhu Z; Zhang L; Hyde L; Chu I; Cohen-Williams M; Palani A
    ACS Med Chem Lett; 2010 Jul; 1(4):184-7. PubMed ID: 24900193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting γ-secretase in breast cancer.
    Han J; Shen Q
    Breast Cancer (Dove Med Press); 2012 Jun; 4():83-90. PubMed ID: 24367196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side Effects.
    Hyde LA; Zhang Q; Del Vecchio RA; Leach PT; Cohen-Williams ME; Chen L; Wong GT; McHugh NA; Chen J; Higgins GA; Asberom T; Li W; Pissarnitski D; Levitan D; Nomeir AA; Clader JW; Zhang L; Parker EM
    Int J Alzheimers Dis; 2013; 2013():823528. PubMed ID: 23573456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch inhibitors for cancer treatment.
    Espinoza I; Miele L
    Pharmacol Ther; 2013 Aug; 139(2):95-110. PubMed ID: 23458608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice.
    Gregory JL; Prada CM; Fine SJ; Garcia-Alloza M; Betensky RA; Arbel-Ornath M; Greenberg SM; Bacskai BJ; Frosch MP
    J Neuropathol Exp Neurol; 2012 Nov; 71(11):1009-17. PubMed ID: 23095848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies targeting amyloid β-protein.
    Schenk D; Basi GS; Pangalos MN
    Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a006387. PubMed ID: 22951439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. γ-Secretase inhibitors and modulators for Alzheimer's disease.
    Wolfe MS
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):89-98. PubMed ID: 22122056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells.
    Jämsä A; Belda O; Edlund M; Lindström E
    J Biomed Sci; 2011 Oct; 18(1):76. PubMed ID: 22018341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease.
    Basi GS; Hemphill S; Brigham EF; Liao A; Aubele DL; Baker J; Barbour R; Bova M; Chen XH; Dappen MS; Eichenbaum T; Goldbach E; Hawkinson J; Lawler-Herbold R; Hu K; Hui T; Jagodzinski JJ; Keim PS; Kholodenko D; Latimer LH; Lee M; Marugg J; Mattson MN; McCauley S; Miller JL; Motter R; Mutter L; Neitzel ML; Ni H; Nguyen L; Quinn K; Ruslim L; Semko CM; Shapiro P; Smith J; Soriano F; Szoke B; Tanaka K; Tang P; Tucker JA; Ye XM; Yu M; Wu J; Xu YZ; Garofalo AW; Sauer JM; Konradi AW; Ness D; Shopp G; Pleiss MA; Freedman SB; Schenk D
    Alzheimers Res Ther; 2010 Dec; 2(6):36. PubMed ID: 21190552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.
    Kounnas MZ; Danks AM; Cheng S; Tyree C; Ackerman E; Zhang X; Ahn K; Nguyen P; Comer D; Mao L; Yu C; Pleynet D; Digregorio PJ; Velicelebi G; Stauderman KA; Comer WT; Mobley WC; Li YM; Sisodia SS; Tanzi RE; Wagner SL
    Neuron; 2010 Sep; 67(5):769-80. PubMed ID: 20826309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.
    Creed MC; Milgram NW
    Age (Dordr); 2010 Sep; 32(3):365-84. PubMed ID: 20640545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.